Skip to main content

Animations

MJFF Publications

3191 - 3200 of 9156 Results
Title
Year
  • Year
  • 2008
  • 2012
  • 2009
  • 2015
  • 2014
  • 2022
  • 2011
  • 2014
  • 2016
  • 2017
  • Summary Details
    OPEN
    Title: Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1172/jci35781
    Citation Count: 196
  • Summary Details
    OPEN
    Title: Heterogeneity of Cholinergic Denervation in Parkinson's Disease without Dementia
    Journal Name: Journal of Cerebral Blood Flow & Metabolism
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/jcbfm.2012.60
    Citation Count: 186
  • Summary Details
    OPEN
    Title: Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1172/jci37617
    Best OA location URL: http://doi.org/10.1172/JCI37617
    Citation Count: 389
  • Summary Details
    OPEN
    Title: Can Parkinson’s disease be cured by stimulating neurogenesis?
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1172/jci80822
    Citation Count: 10
  • Summary Details
    OPEN
    Title: A brain network response to sham surgery
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1172/jci77193
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid Homeostasis
    Journal Name: The Journal of Neuroscience
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1523/jneurosci.1881-21.2022
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Use of Florbetapir-PET for Imaging β-Amyloid Pathology
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2010.2008
    Citation Count: 1110
  • Summary Details
    OPEN
    Title: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032
    Citation Count: 70
  • Summary Details
    OPEN
    Title: Neuroimmunology of the Interleukins 13 and 4
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci6020018
    Citation Count: 126
  • Serum lipid alterations in GBA-associated Parkinson's disease
    2017
    Summary Details
    RESTRICTED
    Title: Serum lipid alterations in GBA-associated Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.026
    Citation Count: 90
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.